Request for Covid-19 Impact Assessment of this Report

Medical Devices

Global Prostate Specific Antigen (PSA) Testing Market Growth (Status and Outlook) 2022-2028

  • LP 4947338
  • 114 Pages
  • April 2022
  • Medical Devices
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Prostate Specific Antigen (PSA) Testing will have significant change from previous year. According to our (LP Information) latest study, the global Prostate Specific Antigen (PSA) Testing market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Prostate Specific Antigen (PSA) Testing market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Prostate Specific Antigen (PSA) Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Prostate Specific Antigen (PSA) Testing market, reaching US$ million by the year 2028. As for the Europe Prostate Specific Antigen (PSA) Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Prostate Specific Antigen (PSA) Testing players cover Cleveland Diagnostics, Abbott, Siemens Healthineers, and DiaSorin, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Specific Antigen (PSA) Testing market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

Radioimmunoassay

Enzyme Immunoassay

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

Hospitals

Clinics

Diagnostic Centers

Research Institute

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

Cleveland Diagnostics

Abbott

Siemens Healthineers

DiaSorin

Roche Holding AG

Beckman Coulter

Mediwatch(LABORIE)

Boditech

Bristol Myers Squibb

GE Healthcare

Endocare

GlaxoSmith Kline

Anixa Biosciences

Ortho Clinical

Fujirebio

Merck

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Prostate Specific Antigen (PSA) Testing Market Size 2017-2028

2.1.2 Prostate Specific Antigen (PSA) Testing Market Size CAGR by Region 2017 VS 2022 VS 2028

2.2 Prostate Specific Antigen (PSA) Testing Segment by Type

2.2.1 Radioimmunoassay

2.2.2 Enzyme Immunoassay

2.3 Prostate Specific Antigen (PSA) Testing Market Size by Type

2.3.1 Prostate Specific Antigen (PSA) Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)

2.3.2 Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

2.4 Prostate Specific Antigen (PSA) Testing Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Diagnostic Centers

2.4.4 Research Institute

2.4.5 Others

2.5 Prostate Specific Antigen (PSA) Testing Market Size by Application

2.5.1 Prostate Specific Antigen (PSA) Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)

2.5.2 Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

3 Prostate Specific Antigen (PSA) Testing Market Size by Player

3.1 Prostate Specific Antigen (PSA) Testing Market Size Market Share by Players

3.1.1 Global Prostate Specific Antigen (PSA) Testing Revenue by Players (2020-2022)

3.1.2 Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Players (2020-2022)

3.2 Global Prostate Specific Antigen (PSA) Testing Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Prostate Specific Antigen (PSA) Testing by Regions

4.1 Prostate Specific Antigen (PSA) Testing Market Size by Regions (2017-2022)

4.2 Americas Prostate Specific Antigen (PSA) Testing Market Size Growth (2017-2022)

4.3 APAC Prostate Specific Antigen (PSA) Testing Market Size Growth (2017-2022)

4.4 Europe Prostate Specific Antigen (PSA) Testing Market Size Growth (2017-2022)

4.5 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Growth (2017-2022)

5 Americas

5.1 Americas Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022)

5.2 Americas Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)

5.3 Americas Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022)

6.2 APAC Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)

6.3 APAC Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Prostate Specific Antigen (PSA) Testing by Country (2017-2022)

7.2 Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)

7.3 Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Prostate Specific Antigen (PSA) Testing by Region (2017-2022)

8.2 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022)

8.3 Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Global Prostate Specific Antigen (PSA) Testing Market Forecast

10.1 Global Prostate Specific Antigen (PSA) Testing Forecast by Regions (2023-2028)

10.1.1 Global Prostate Specific Antigen (PSA) Testing Forecast by Regions (2023-2028)

10.1.2 Americas Prostate Specific Antigen (PSA) Testing Forecast

10.1.3 APAC Prostate Specific Antigen (PSA) Testing Forecast

10.1.4 Europe Prostate Specific Antigen (PSA) Testing Forecast

10.1.5 Middle East & Africa Prostate Specific Antigen (PSA) Testing Forecast

10.2 Americas Prostate Specific Antigen (PSA) Testing Forecast by Country (2023-2028)

10.2.1 United States Prostate Specific Antigen (PSA) Testing Market Forecast

10.2.2 Canada Prostate Specific Antigen (PSA) Testing Market Forecast

10.2.3 Mexico Prostate Specific Antigen (PSA) Testing Market Forecast

10.2.4 Brazil Prostate Specific Antigen (PSA) Testing Market Forecast

10.3 APAC Prostate Specific Antigen (PSA) Testing Forecast by Region (2023-2028)

10.3.1 China Prostate Specific Antigen (PSA) Testing Market Forecast

10.3.2 Japan Prostate Specific Antigen (PSA) Testing Market Forecast

10.3.3 Korea Prostate Specific Antigen (PSA) Testing Market Forecast

10.3.4 Southeast Asia Prostate Specific Antigen (PSA) Testing Market Forecast

10.3.5 India Prostate Specific Antigen (PSA) Testing Market Forecast

10.3.6 Australia Prostate Specific Antigen (PSA) Testing Market Forecast

10.4 Europe Prostate Specific Antigen (PSA) Testing Forecast by Country (2023-2028)

10.4.1 Germany Prostate Specific Antigen (PSA) Testing Market Forecast

10.4.2 France Prostate Specific Antigen (PSA) Testing Market Forecast

10.4.3 UK Prostate Specific Antigen (PSA) Testing Market Forecast

10.4.4 Italy Prostate Specific Antigen (PSA) Testing Market Forecast

10.4.5 Russia Prostate Specific Antigen (PSA) Testing Market Forecast

10.5 Middle East & Africa Prostate Specific Antigen (PSA) Testing Forecast by Region (2023-2028)

10.5.1 Egypt Prostate Specific Antigen (PSA) Testing Market Forecast

10.5.2 South Africa Prostate Specific Antigen (PSA) Testing Market Forecast

10.5.3 Israel Prostate Specific Antigen (PSA) Testing Market Forecast

10.5.4 Turkey Prostate Specific Antigen (PSA) Testing Market Forecast

10.5.5 GCC Countries Prostate Specific Antigen (PSA) Testing Market Forecast

10.6 Global Prostate Specific Antigen (PSA) Testing Forecast by Type (2023-2028)

10.7 Global Prostate Specific Antigen (PSA) Testing Forecast by Application (2023-2028)

11 Key Players Analysis

11.1 Cleveland Diagnostics

11.1.1 Cleveland Diagnostics Company Information

11.1.2 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Offered

11.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.1.4 Cleveland Diagnostics Main Business Overview

11.1.5 Cleveland Diagnostics Latest Developments

11.2 Abbott

11.2.1 Abbott Company Information

11.2.2 Abbott Prostate Specific Antigen (PSA) Testing Product Offered

11.2.3 Abbott Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.2.4 Abbott Main Business Overview

11.2.5 Abbott Latest Developments

11.3 Siemens Healthineers

11.3.1 Siemens Healthineers Company Information

11.3.2 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Offered

11.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.3.4 Siemens Healthineers Main Business Overview

11.3.5 Siemens Healthineers Latest Developments

11.4 DiaSorin

11.4.1 DiaSorin Company Information

11.4.2 DiaSorin Prostate Specific Antigen (PSA) Testing Product Offered

11.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.4.4 DiaSorin Main Business Overview

11.4.5 DiaSorin Latest Developments

11.5 Roche Holding AG

11.5.1 Roche Holding AG Company Information

11.5.2 Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Offered

11.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.5.4 Roche Holding AG Main Business Overview

11.5.5 Roche Holding AG Latest Developments

11.6 Beckman Coulter

11.6.1 Beckman Coulter Company Information

11.6.2 Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Offered

11.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.6.4 Beckman Coulter Main Business Overview

11.6.5 Beckman Coulter Latest Developments

11.7 Mediwatch(LABORIE)

11.7.1 Mediwatch(LABORIE) Company Information

11.7.2 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Offered

11.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.7.4 Mediwatch(LABORIE) Main Business Overview

11.7.5 Mediwatch(LABORIE) Latest Developments

11.8 Boditech

11.8.1 Boditech Company Information

11.8.2 Boditech Prostate Specific Antigen (PSA) Testing Product Offered

11.8.3 Boditech Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.8.4 Boditech Main Business Overview

11.8.5 Boditech Latest Developments

11.9 Bristol Myers Squibb

11.9.1 Bristol Myers Squibb Company Information

11.9.2 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Offered

11.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.9.4 Bristol Myers Squibb Main Business Overview

11.9.5 Bristol Myers Squibb Latest Developments

11.10 GE Healthcare

11.10.1 GE Healthcare Company Information

11.10.2 GE Healthcare Prostate Specific Antigen (PSA) Testing Product Offered

11.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.10.4 GE Healthcare Main Business Overview

11.10.5 GE Healthcare Latest Developments

11.11 Endocare

11.11.1 Endocare Company Information

11.11.2 Endocare Prostate Specific Antigen (PSA) Testing Product Offered

11.11.3 Endocare Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.11.4 Endocare Main Business Overview

11.11.5 Endocare Latest Developments

11.12 GlaxoSmith Kline

11.12.1 GlaxoSmith Kline Company Information

11.12.2 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Offered

11.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.12.4 GlaxoSmith Kline Main Business Overview

11.12.5 GlaxoSmith Kline Latest Developments

11.13 Anixa Biosciences

11.13.1 Anixa Biosciences Company Information

11.13.2 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Offered

11.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.13.4 Anixa Biosciences Main Business Overview

11.13.5 Anixa Biosciences Latest Developments

11.14 Ortho Clinical

11.14.1 Ortho Clinical Company Information

11.14.2 Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Offered

11.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.14.4 Ortho Clinical Main Business Overview

11.14.5 Ortho Clinical Latest Developments

11.15 Fujirebio

11.15.1 Fujirebio Company Information

11.15.2 Fujirebio Prostate Specific Antigen (PSA) Testing Product Offered

11.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.15.4 Fujirebio Main Business Overview

11.15.5 Fujirebio Latest Developments

11.16 Merck

11.16.1 Merck Company Information

11.16.2 Merck Prostate Specific Antigen (PSA) Testing Product Offered

11.16.3 Merck Prostate Specific Antigen (PSA) Testing Revenue, Gross Margin and Market Share (2020-2022)

11.16.4 Merck Main Business Overview

11.16.5 Merck Latest Developments

12 Research Findings and Conclusion

List of Tables

Table 1. Prostate Specific Antigen (PSA) Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)

Table 2. Major Players of Radioimmunoassay

Table 3. Major Players of Enzyme Immunoassay

Table 4. Prostate Specific Antigen (PSA) Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)

Table 5. Global Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & ($ Millions)

Table 6. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

Table 7. Prostate Specific Antigen (PSA) Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)

Table 8. Global Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & ($ Millions)

Table 9. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

Table 10. Global Prostate Specific Antigen (PSA) Testing Revenue by Players (2020-2022) & ($ Millions)

Table 11. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Player (2020-2022)

Table 12. Prostate Specific Antigen (PSA) Testing Key Players Head office and Products Offered

Table 13. Prostate Specific Antigen (PSA) Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 14. New Products and Potential Entrants

Table 15. Mergers & Acquisitions, Expansion

Table 16. Global Prostate Specific Antigen (PSA) Testing Market Size by Regions 2017-2022 & ($ Millions)

Table 17. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Regions (2017-2022)

Table 18. Americas Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & ($ Millions)

Table 19. Americas Prostate Specific Antigen (PSA) Testing Market Size Market Share by Country (2017-2022)

Table 20. Americas Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & ($ Millions)

Table 21. Americas Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

Table 22. Americas Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & ($ Millions)

Table 23. Americas Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

Table 24. APAC Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022) & ($ Millions)

Table 25. APAC Prostate Specific Antigen (PSA) Testing Market Size Market Share by Region (2017-2022)

Table 26. APAC Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & ($ Millions)

Table 27. APAC Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

Table 28. APAC Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & ($ Millions)

Table 29. APAC Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

Table 30. Europe Prostate Specific Antigen (PSA) Testing Market Size by Country (2017-2022) & ($ Millions)

Table 31. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Country (2017-2022)

Table 32. Europe Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & ($ Millions)

Table 33. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

Table 34. Europe Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & ($ Millions)

Table 35. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

Table 36. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Region (2017-2022) & ($ Millions)

Table 37. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Region (2017-2022)

Table 38. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Type (2017-2022) & ($ Millions)

Table 39. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type (2017-2022)

Table 40. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size by Application (2017-2022) & ($ Millions)

Table 41. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application (2017-2022)

Table 42. Key Market Drivers & Growth Opportunities of Prostate Specific Antigen (PSA) Testing

Table 43. Key Market Challenges & Risks of Prostate Specific Antigen (PSA) Testing

Table 44. Key Industry Trends of Prostate Specific Antigen (PSA) Testing

Table 45. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)

Table 46. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share Forecast by Regions (2023-2028)

Table 47. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Type (2023-2028) & ($ Millions)

Table 48. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share Forecast by Type (2023-2028)

Table 49. Global Prostate Specific Antigen (PSA) Testing Market Size Forecast by Application (2023-2028) & ($ Millions)

Table 50. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share Forecast by Application (2023-2028)

Table 51. Cleveland Diagnostics Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 52. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Offered

Table 53. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 54. Cleveland Diagnostics Main Business

Table 55. Cleveland Diagnostics Latest Developments

Table 56. Abbott Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 57. Abbott Prostate Specific Antigen (PSA) Testing Product Offered

Table 58. Abbott Main Business

Table 59. Abbott Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 60. Abbott Latest Developments

Table 61. Siemens Healthineers Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 62. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Offered

Table 63. Siemens Healthineers Main Business

Table 64. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 65. Siemens Healthineers Latest Developments

Table 66. DiaSorin Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 67. DiaSorin Prostate Specific Antigen (PSA) Testing Product Offered

Table 68. DiaSorin Main Business

Table 69. DiaSorin Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 70. DiaSorin Latest Developments

Table 71. Roche Holding AG Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 72. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Offered

Table 73. Roche Holding AG Main Business

Table 74. Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 75. Roche Holding AG Latest Developments

Table 76. Beckman Coulter Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 77. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Offered

Table 78. Beckman Coulter Main Business

Table 79. Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 80. Beckman Coulter Latest Developments

Table 81. Mediwatch(LABORIE) Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 82. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Offered

Table 83. Mediwatch(LABORIE) Main Business

Table 84. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 85. Mediwatch(LABORIE) Latest Developments

Table 86. Boditech Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 87. Boditech Prostate Specific Antigen (PSA) Testing Product Offered

Table 88. Boditech Main Business

Table 89. Boditech Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 90. Boditech Latest Developments

Table 91. Bristol Myers Squibb Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 92. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Offered

Table 93. Bristol Myers Squibb Main Business

Table 94. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 95. Bristol Myers Squibb Latest Developments

Table 96. GE Healthcare Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 97. GE Healthcare Prostate Specific Antigen (PSA) Testing Product Offered

Table 98. GE Healthcare Main Business

Table 99. GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 100. GE Healthcare Latest Developments

Table 101. Endocare Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 102. Endocare Prostate Specific Antigen (PSA) Testing Product Offered

Table 103. Endocare Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 104. Endocare Main Business

Table 105. Endocare Latest Developments

Table 106. GlaxoSmith Kline Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 107. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Offered

Table 108. GlaxoSmith Kline Main Business

Table 109. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 110. GlaxoSmith Kline Latest Developments

Table 111. Anixa Biosciences Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 112. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Offered

Table 113. Anixa Biosciences Main Business

Table 114. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 115. Anixa Biosciences Latest Developments

Table 116. Ortho Clinical Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 117. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Offered

Table 118. Ortho Clinical Main Business

Table 119. Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 120. Ortho Clinical Latest Developments

Table 121. Fujirebio Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 122. Fujirebio Prostate Specific Antigen (PSA) Testing Product Offered

Table 123. Fujirebio Main Business

Table 124. Fujirebio Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 125. Fujirebio Latest Developments

Table 126. Merck Details, Company Type, Prostate Specific Antigen (PSA) Testing Area Served and Its Competitors

Table 127. Merck Prostate Specific Antigen (PSA) Testing Product Offered

Table 128. Merck Main Business

Table 129. Merck Prostate Specific Antigen (PSA) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)

Table 130. Merck Latest Developments

List of Figures

Figure 1. Prostate Specific Antigen (PSA) Testing Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Prostate Specific Antigen (PSA) Testing Market Size Growth Rate 2017-2028 ($ Millions)

Figure 6. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type in 2021

Figure 7. Prostate Specific Antigen (PSA) Testing in Hospitals

Figure 8. Global Prostate Specific Antigen (PSA) Testing Market: Hospitals (2017-2022) & ($ Millions)

Figure 9. Prostate Specific Antigen (PSA) Testing in Clinics

Figure 10. Global Prostate Specific Antigen (PSA) Testing Market: Clinics (2017-2022) & ($ Millions)

Figure 11. Prostate Specific Antigen (PSA) Testing in Diagnostic Centers

Figure 12. Global Prostate Specific Antigen (PSA) Testing Market: Diagnostic Centers (2017-2022) & ($ Millions)

Figure 13. Prostate Specific Antigen (PSA) Testing in Research Institute

Figure 14. Global Prostate Specific Antigen (PSA) Testing Market: Research Institute (2017-2022) & ($ Millions)

Figure 15. Prostate Specific Antigen (PSA) Testing in Others

Figure 16. Global Prostate Specific Antigen (PSA) Testing Market: Others (2017-2022) & ($ Millions)

Figure 17. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application in 2021

Figure 18. Global Prostate Specific Antigen (PSA) Testing Revenue Market Share by Player in 2021

Figure 19. Global Prostate Specific Antigen (PSA) Testing Market Size Market Share by Regions (2017-2022)

Figure 20. Americas Prostate Specific Antigen (PSA) Testing Market Size 2017-2022 ($ Millions)

Figure 21. APAC Prostate Specific Antigen (PSA) Testing Market Size 2017-2022 ($ Millions)

Figure 22. Europe Prostate Specific Antigen (PSA) Testing Market Size 2017-2022 ($ Millions)

Figure 23. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size 2017-2022 ($ Millions)

Figure 24. Americas Prostate Specific Antigen (PSA) Testing Value Market Share by Country in 2021

Figure 25. Americas Prostate Specific Antigen (PSA) Testing Consumption Market Share by Type in 2021

Figure 26. Americas Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application in 2021

Figure 27. United States Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 28. Canada Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 29. Mexico Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 30. Brazil Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 31. APAC Prostate Specific Antigen (PSA) Testing Market Size Market Share by Region in 2021

Figure 32. APAC Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application in 2021

Figure 33. China Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 34. Japan Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 35. Korea Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 36. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 37. India Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 38. Australia Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 39. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Country in 2021

Figure 40. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type in 2021

Figure 41. Europe Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application in 2021

Figure 42. Germany Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 43. France Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 44. UK Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 45. Italy Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 46. Russia Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 47. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Region in 2021

Figure 48. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Type in 2021

Figure 49. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size Market Share by Application in 2021

Figure 50. Egypt Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 51. South Africa Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 52. Israel Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 53. Turkey Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 54. GCC Country Prostate Specific Antigen (PSA) Testing Market Size Growth 2017-2022 ($ Millions)

Figure 55. Americas Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 56. APAC Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 57. Europe Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 58. Middle East & Africa Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 59. United States Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 60. Canada Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 61. Mexico Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 62. Brazil Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 63. China Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 64. Japan Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 65. Korea Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 66. Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 67. India Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 68. Australia Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 69. Germany Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 70. France Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 71. UK Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 72. Italy Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 73. Russia Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 74. Spain Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 75. Egypt Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 76. South Africa Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 77. Israel Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 78. Turkey Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

Figure 79. GCC Countries Prostate Specific Antigen (PSA) Testing Market Size 2023-2028 ($ Millions)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

France Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares

  • Publish Date: April 1, 2019
  • $450
Germany Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
    &nb...

  • Publish Date: April 1, 2019
  • $450
Italy Molecular Diagnostics Market Shares and Sales Forecasts by Test and Application, 2019-2023

This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.

Table of Contents

Business Environment
 
Market Structure
 
Market Size, Growth, and Major Suppliers' Market Shares
 &nb...

  • Publish Date: April 1, 2019
  • $450